BioCentury | Apr 6, 2018
Emerging Company Profile
Tiny taxanes
...increase the efficacy and reduce the side effects associated with systemic administration. Formed in 2015, NanOlogy...
...solvents currently required for standard systemic delivery of chemotherapeutic drugs, and allowing for local delivery. NanOlogy...
...is limited by their short half-lives and low bioavailability. He said that the geometry of NanOlogy’s...
...solvents currently required for standard systemic delivery of chemotherapeutic drugs, and allowing for local delivery. NanOlogy...
...is limited by their short half-lives and low bioavailability. He said that the geometry of NanOlogy’s...